SF1670,
SF1670,
345630-40-2,
PTP CD45 Inhibitor,
PTPase CD45 Inhibitor,
CHEMBL51314,
SF 1670,
Protein Tyrosine Phosphatase CD45 Inhibitor,
N-(9,10-Dihydro-9,10-dioxo-2-phenanthrenyl)-2,2-dimethyl-propanamide,
N-(9,10-Dioxo-9,10-dihydro-phenanthren-2-yl)-2,2-dimethyl-propionamide,
N-(9,10-dioxo-9,10-dihydrophenanthren-2-yl)pivalamide,
PTP Inhibitor XIX,
SF1670(PTENinhibitor),
SF1670?PTEN inhibitor?,
SCHEMBL458603,
SF1670 (PTEN inhibitor),
HMS3653A12,
BCP08444,
EX-A2439,
2713AH,
BDBM50099692,
HSCI1_000333,
s7310,
ZINC13862833,
AKOS027470157,
CS-6115,
NCGC00187646-01,
SF 1670;SF-1670,
AK685537,
BP-22844,
HY-15842,
SW219904-1,
J-019646,
BRD-K21357983-001-01-3,
N-(9,10-dihydro-9,10-dioxophenanthren-7-yl)pivalamide,
N-(9,10-dioxophenanthren-2-yl)-2,2-dimethylpropanamide,
N-(9,10-Dihydro-9,10-dioxo-2-phenanthrenyl)-2,2-dimethylpropanamide,
N-(9,10-Dioxo-9,10-dihydro-phenanthrene-2-yl)-2,2-dimethyl-propionamide,
N-(9,10-dioxo-9,10-dihydrophenanthren-2-yl)-2,2-dimethylpropionamide,
N-(9,10-Dioxo-9,10-dihydrophenanthrene-2-yl)-2,2-dimethylpropionamide,
Propanamide, N-(9,10-dihydro-9,10-dioxo-2-phenanthrenyl)-2,2-dimethyl-,
C19H17NO3,
CID9926586,
A13475,
N-(9,10-dioxophenanthren-2-yl)-2,2-dimethyl-propanamide,